Sepsis Diagnostics Global Market Report 2025

Description

Sepsis diagnostics refers to a range of advanced technologies and tests designed to quickly detect the presence of sepsis, a critical condition that can lead to organ failure and death if not treated promptly. These diagnostic tools enable healthcare providers to assess the severity of sepsis and make timely, informed decisions to initiate appropriate treatments, ultimately improving patient survival rates.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main products in sepsis diagnostics include instruments, blood culture media, assay kits and reagents, and software. Instruments are medical devices used to rapidly analyze blood samples and detect pathogens, allowing for the early and accurate identification of sepsis and facilitating timely treatment. Sepsis diagnostics employ various technologies such as microbiology, molecular diagnostics, immunoassays, and flow cytometry to detect different types of pathogens, including bacterial, fungal, viral sepsis, and others. The diagnostic methods include both automated and conventional diagnostic approaches. These tools are used by various end-users, including hospitals and clinics, pathology and reference laboratories, and research institutes.

The sepsis diagnostics market research report is one of a series of new reports from The Business Research Company that provides sepsis diagnostics market statistics, including the sepsis diagnostics industry global market size, regional shares, competitors with the sepsis diagnostics market share, detailed sepsis diagnostics market segments, market trends, and opportunities, and any further data you may need to thrive in the sepsis diagnostics industry. This sepsis diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The sepsis diagnostics market size has grown strongly in recent years. It will grow from $0.99 billion in 2024 to $1.07 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth during the historic period can be attributed to the increasing incidence of sepsis, growing awareness about the importance of early diagnosis, rising healthcare expenditure, a growing prevalence of hospital-acquired infections, and the increasing adoption of point-of-care testing.

The sepsis diagnostics market size is expected to see strong growth in the next few years. It will grow to $1.47 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth during the forecast period can be attributed to the rising demand for rapid diagnostics, increasing investments in healthcare infrastructure, a growing focus on personalized medicine, the increasing prevalence of antimicrobial resistance, and the rising use of next-generation sequencing. Key trends expected in the forecast period include the integration of AI in diagnostics, technological advancements in biomarkers, progress in molecular diagnostics, a shift toward automated and digital diagnostic platforms, and the continued advancement of artificial intelligence in diagnostics.

The rising incidence of hospital-acquired infections (HAIs) is expected to drive growth in the sepsis diagnostics market. HAIs are infections that develop during or after a patient's stay in a healthcare facility, typically 48 hours or more after admission, and were not present at the time of admission. The increase in HAIs is largely due to the growing issue of antibiotic resistance. Overuse and misuse of antibiotics in healthcare settings have led to the development of resistant bacteria, making infections more difficult to treat. Sepsis diagnostics play a critical role by enabling early detection of hospital-acquired infections, identifying pathogens and biomarkers that allow for timely treatment and reduced complications. For instance, in November 2024, the Australian Institute of Health and Welfare reported that in 2022-2023, healthcare-associated infections (HACs) occurred in 2% of public hospital admissions and 0.8% of private hospital admissions, with HAIs being the most frequent complication. As a result, the rising incidence of hospital-acquired infections is significantly driving the sepsis diagnostics market.

Key players in the sepsis diagnostics market are focusing on the development of innovative solutions, such as culture-free diagnostic systems, to enable rapid and accurate detection of sepsis without relying on traditional blood cultures. Culture-free diagnostics leverage advanced technologies, including polymerase chain reaction (PCR), next-generation sequencing (NGS), or immunoassays, to identify pathogens directly from patient samples such as blood, saliva, or tissue. For example, in April 2024, Deepull Diagnostics S.L., a Spain-based company, launched the UllCORE diagnostic system for early sepsis detection. This culture-free, multiplex PCR platform provides rapid pathogen identification in sepsis and other acute infections. The system extracts microbial DNA from 8 mL of whole blood, offering 50 reportable results in just one hour. It detects 95% of sepsis-causing pathogens, including bacteria, fungi, and antibiotic resistance genes, helping hospitals combat antimicrobial resistance while improving early diagnosis and reducing antibiotic misuse.

In October 2024, Trinity Biotech plc, an Ireland-based medical laboratory company, acquired a 12.5% stake in Novus Diagnostics Ltd. for $2.5 million. This acquisition aims to accelerate the development and commercialization of Novus Diagnostics' rapid point-of-care diagnostic solutions, particularly its 15-minute bloodstream infection test. This rapid test is expected to significantly enhance sepsis diagnosis and improve patient outcomes by enabling faster and more accurate testing for bloodstream infections. Novus Diagnostics is an Ireland-based medical technology company developing diagnostic solutions for sepsis and other bloodstream infections.

Major players in the sepsis diagnostics market are Siemens Healthcare GmbH, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton, Dickinson and Company, Koninklijke Philips N.V., GE Healthcare, Wolters Kluwer N.V., bioMerieux S.A., Bruker Corporation, DiaSorin S.p.A., Cepheid Inc., Seegene Inc., Luminex Corporation, T2 Biosystems Inc., Cytovale Inc., Accelerate Diagnostics Inc., Immunexpress Inc., Sepsis Alliance.

North America was the largest region in the sepsis diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in sepsis diagnostics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the sepsis diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sepsis diagnostics market consists of revenues earned by entities by providing services such as clinical consultation, rapid diagnostic testing solutions, point-of-care diagnostic solutions, biomarker testing, and molecular diagnostic testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The sepsis diagnostics market also includes sales of sepsis diagnostic test kits, automated blood culture systems, molecular diagnostic equipment, sepsis biomarker assay kits, and rapid diagnostic devices for infection detection. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sepsis Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sepsis diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for sepsis diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sepsis diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product: Instruments; Blood Culture Media; Assay Kits And Reagents; Software
2) By Technology: Microbiology; Molecular Diagnostics; Immunoassays; Flow Cytometry; Other Technologies
3) By Pathogen: Bacterial Sepsis; Fungal Sepsis; Viral Sepsis; Other Pathogens
4) By Method: Automated Diagnostics; Conventional Diagnostics
5) By End-Users: Hospitals And Clinics; Pathology And Reference Laboratories; Research Institutes
Subsegments:
1) By Instruments: Automated Analyzers; Point-Of-Care (PoC) Testing Devices; Microfluidic-Based Devices; Polymerase Chain Reaction (PCR) Instruments; Flow Cytometers
2) By Blood Culture Media: Aerobic Blood Culture Media; Anaerobic Blood Culture Media; Mycobacteria Blood Culture Media; Pediatric Blood Culture Media; Fungal Blood Culture Media
3) By Assay Kits And Reagents: Enzyme-Linked Immunosorbent Assay (ELISA) Kits; Polymerase Chain Reaction (PCR) Assay Kits; Immunoassay Reagents; Molecular Diagnostic Reagents; Biosensor-Based Assay Kits
4) By Software: Data Management Software; Laboratory Information Systems (LIS); Artificial Intelligence (AI)-Based Diagnostic Tools; Predictive Analytics Software; Cloud-Based Diagnostic Platforms
Companies Mentioned: Siemens Healthcare GmbH; F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r34966

1. Executive Summary

2. Sepsis Diagnostics Market Characteristics

3. Sepsis Diagnostics Market Trends And Strategies

4. Sepsis Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Sepsis Diagnostics Growth Analysis And Strategic Analysis Framework

5.1. Global Sepsis Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Sepsis Diagnostics Market Growth Rate Analysis
5.4. Global Sepsis Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Sepsis Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Sepsis Diagnostics Total Addressable Market (TAM)

6. Sepsis Diagnostics Market Segmentation

6.1. Global Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Instruments
Blood Culture Media
Assay Kits And Reagents
Software
6.2. Global Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Microbiology
Molecular Diagnostics
Immunoassays
Flow Cytometry
Other Technologies
6.3. Global Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bacterial Sepsis
Fungal Sepsis
Viral Sepsis
Other Pathogens
6.4. Global Sepsis Diagnostics Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Automated Diagnostics
Conventional Diagnostics
6.5. Global Sepsis Diagnostics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Pathology And Reference Laboratories
Research Institutes
6.6. Global Sepsis Diagnostics Market, Sub-Segmentation Of Instruments, By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Automated Analyzers
Point-Of-Care (Poc) Testing Devices
Microfluidic-Based Devices
Polymerase Chain Reaction (Pcr) Instruments
Flow Cytometers
6.7. Global Sepsis Diagnostics Market, Sub-Segmentation Of Blood Culture Media, By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Aerobic Blood Culture Media
Anaerobic Blood Culture Media
Mycobacteria Blood Culture Media
Pediatric Blood Culture Media
Fungal Blood Culture Media
6.8. Global Sepsis Diagnostics Market, Sub-Segmentation Of Assay Kits And Reagents, By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Enzyme-Linked Immunosorbent Assay (Elisa) Kits
Polymerase Chain Reaction (Pcr) Assay Kits
Immunoassay Reagents
Molecular Diagnostic Reagents
Biosensor-Based Assay Kits
6.9. Global Sepsis Diagnostics Market, Sub-Segmentation Of Software, By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Data Management Software
Laboratory Information Systems (Lis)
Artificial Intelligence (Ai)-Based Diagnostic Tools
Predictive Analytics Software
Cloud-Based Diagnostic Platforms

7. Sepsis Diagnostics Market Regional And Country Analysis

7.1. Global Sepsis Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Sepsis Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Sepsis Diagnostics Market

8.1. Asia-Pacific Sepsis Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Sepsis Diagnostics Market

9.1. China Sepsis Diagnostics Market Overview
9.2. China Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Sepsis Diagnostics Market

10.1. India Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Sepsis Diagnostics Market

11.1. Japan Sepsis Diagnostics Market Overview
11.2. Japan Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Sepsis Diagnostics Market

12.1. Australia Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Sepsis Diagnostics Market

13.1. Indonesia Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Sepsis Diagnostics Market

14.1. South Korea Sepsis Diagnostics Market Overview
14.2. South Korea Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Sepsis Diagnostics Market

15.1. Western Europe Sepsis Diagnostics Market Overview
15.2. Western Europe Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Sepsis Diagnostics Market

16.1. UK Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Sepsis Diagnostics Market

17.1. Germany Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Sepsis Diagnostics Market

18.1. France Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Sepsis Diagnostics Market

19.1. Italy Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Sepsis Diagnostics Market

20.1. Spain Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Sepsis Diagnostics Market

21.1. Eastern Europe Sepsis Diagnostics Market Overview
21.2. Eastern Europe Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Sepsis Diagnostics Market

22.1. Russia Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Sepsis Diagnostics Market

23.1. North America Sepsis Diagnostics Market Overview
23.2. North America Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Sepsis Diagnostics Market

24.1. USA Sepsis Diagnostics Market Overview
24.2. USA Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Sepsis Diagnostics Market

25.1. Canada Sepsis Diagnostics Market Overview
25.2. Canada Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Sepsis Diagnostics Market

26.1. South America Sepsis Diagnostics Market Overview
26.2. South America Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Sepsis Diagnostics Market

27.1. Brazil Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Sepsis Diagnostics Market

28.1. Middle East Sepsis Diagnostics Market Overview
28.2. Middle East Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Sepsis Diagnostics Market

29.1. Africa Sepsis Diagnostics Market Overview
29.2. Africa Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Sepsis Diagnostics Market Competitive Landscape And Company Profiles

30.1. Sepsis Diagnostics Market Competitive Landscape
30.2. Sepsis Diagnostics Market Company Profiles
- 30.2.1. Siemens Healthcare GmbH Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Sepsis Diagnostics Market Other Major And Innovative Companies

31.1. Becton, Dickinson and Company
31.2. Koninklijke Philips N.V.
31.3. GE Healthcare
31.4. Wolters Kluwer N.V.
31.5. bioMerieux S.A.
31.6. Bruker Corporation
31.7. DiaSorin S.p.A.
31.8. Cepheid Inc.
31.9. Seegene Inc.
31.10. Luminex Corporation
31.11. T2 Biosystems Inc.
31.12. Cytovale Inc.
31.13. Accelerate Diagnostics Inc.
31.14. Immunexpress Inc.
31.15. Sepsis Alliance

32. Global Sepsis Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Sepsis Diagnostics Market

34. Recent Developments In The Sepsis Diagnostics Market

35. Sepsis Diagnostics Market High Potential Countries, Segments and Strategies

35.1 Sepsis Diagnostics Market In 2029 - Countries Offering Most New Opportunities
35.2 Sepsis Diagnostics Market In 2029 - Segments Offering Most New Opportunities
35.3 Sepsis Diagnostics Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
250617_r34966_Sepsis_Diagnostics_GMR_2025